<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cyclin-dependent kinase inhibitor p27 is a negative regulator of the transition from G1 to S phase of the cell cycle, protects against inflammatory injury and promotes epithelial differentiation </plain></SENT>
<SENT sid="1" pm="."><plain>Because p27 protein has been shown to be abnormally expressed both in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> associated with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and in <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>, we used immunohistochemistry to evaluate p27 expression in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD)-associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath>, inflamed, and transitional mucosa, <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_270'>adenomas</z:mpath>, and <z:hpo ids='HP_0003745'>sporadic</z:hpo> colonic <z:mp ids='MP_0002038'>carcinomas</z:mp> were studied as controls </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> colonic epithelium p27 expression was restricted to the superficial, terminally differentiated cells </plain></SENT>
<SENT sid="4" pm="."><plain>In colitic and inflamed diverticular mucosa p27 was expressed in the base of the crypts in 86 and 70% of cases, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, in transitional mucosa adjacent to <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mp ids='MP_0002038'>carcinomas</z:mp> p27 was expressed in the base of the crypts in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="6" pm="."><plain>Strong p27 expression extended more frequently from the base of the crypts to superficial cells in IBD-associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> than in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_270'>adenomas</z:mpath> (P &lt; 0.007) </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty of 20 (100%) IBD-associated <z:mp ids='MP_0002038'>carcinomas</z:mp> showed low p27 expression (&lt;50% nuclei positive) compared to 6 of 20 (30%) stage-matched <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude (i) aberrant p27 protein expression in inflamed and IBD-associated nondysplastic mucosa is indistinguishable from that found in transitional mucosa adjacent to <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mp ids='MP_0002038'>carcinomas</z:mp>; (ii) p27 is overexpressed in dysplastic lesions, perhaps as an attempt to counterbalance proliferative stimuli; and (iii) IBD-associated colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> have significantly lower p27 expression, commonly associated with poor prognosis, than stage-matched <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings further substantiate the existence of divergent molecular pathogenetic pathways between these types of <z:mp ids='MP_0002038'>carcinomas</z:mp> and suggest an intrinsically more <z:hpo ids='HP_0000718'>aggressive behavior</z:hpo> of IBD-associated colon <z:mp ids='MP_0002038'>carcinomas</z:mp> compared to <z:hpo ids='HP_0003745'>sporadic</z:hpo> ones </plain></SENT>
</text></document>